In­flu­en­tial Third Rock Ven­tures marks a decade of high-pro­file wins and loss­es with record $616M Fund IV

In the 10 years since Third Rock Ven­tures was found­ed, the VC group has been one of the in­dus­try’s most in­flu­en­tial trend­set­ters in cre­at­ing the past gen­er­a­tion of biotech­nol­o­gy up­starts. And now it’s lined up a record $616 mil­lion for its fourth fund to be­gin its sec­ond decade.

The new fund bring its to­tal take to close to $2 bil­lion. And in this next wave found­ing part­ners Mark Levin and Kevin Starr — among the Mil­len­ni­um vet­er­ans who played in­stru­men­tal roles ear­ly on — will be ad­vi­sors on­ly as they con­tin­ue to shep­herd their ear­li­er plays. A group of 8 part­ners, in­clud­ing the new­ly named part­ner Ab­bie Cel­niker and the new­ly pro­mot­ed Charles Hom­cy, will take the lead in do­ing the heavy lift­ing on com­pa­ny cre­ation for Fund IV, which for Third Rock of­ten in­volves an in­ter­im stint as CEO of the com­pa­nies it spawns.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.